Quantum Biopharma Ltd. (QNTM) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Quantum Biopharma Ltd. (QNTM:NASDAQ), powered by AI.

Current Price
$3.64
P/E Ratio
-0.5
Market Cap
12M
Sector
Healthcare
What is the Quantum Biopharma Ltd. stock price forecast?

Quantum Biopharma Ltd. is currently trading at $3.64. View real-time AI analysis on Alpha Lenz.

What is Quantum Biopharma Ltd. insider trading activity?

View the latest insider trading data for Quantum Biopharma Ltd. on Alpha Lenz.

What is Quantum Biopharma Ltd.'s P/E ratio?

Quantum Biopharma Ltd.'s P/E ratio is -0.5.

Quantum Biopharma Ltd.

NASDAQ · QNTM
$3.64-0.06(-1.62%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Quantum Biopharma Ltd.'s future dividend policy...
Alpha Chat Insight

Quantum Biopharma Ltd. trades at a P/E of -0.5 (undervalued) with modest ROE of -284.4%.

Ask for details

Company Overview

Quantum Biopharma Ltd. is a biopharmaceutical company dedicated to the development, manufacturing, and commercialization of innovative therapies. Its primary function is to harness cutting-edge biotechnology to address unmet medical needs in various critical areas. Quantum Biopharma engages in extensive research and development to discover novel drug candidates, utilizing advanced technologies such as genetic engineering and precision medicine. The company focuses on therapeutic fields including oncology, neurology, and rare genetic disorders, significantly impacting the healthcare and pharmaceutical sectors. With a commitment to improving patient outcomes, Quantum Biopharma collaborates with academic institutions and strategic partners to enhance its drug development pipeline. As a key player in the biopharmaceutical market, Quantum Biopharma holds a pivotal role in driving forward medical innovation and expanding the availability of life-saving treatments. By advancing its product portfolio through rigorous clinical trials and regulatory approvals, Quantum Biopharma continues to contribute to the global healthcare landscape, addressing complex health challenges and promoting wellness.

CEOMr. Zeeshan Saeed
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees17

Company Statistics

FY 2025

Profile

$11.96MMarket Cap
$0.00Revenue
0.00Shares Out
17Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

-0.46P/E
1.73P/B
N/AEV/Sales
-0.72EV/EBITDA
-1.45P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-190.64%ROA
-284.44%ROE
-186.27%ROIC

Financial Health

$1.91MCash & Cash Equivalents
$4.15MNet Debt
118.73%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Quantum Biopharma Ltd. (ticker: QNTM) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 17 employees. Market cap is $12M.

The current price is $3.64 with a P/E ratio of -0.46x and P/B of 1.73x.

ROE is -284.44%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Quantum Biopharma Ltd. (QNTM) Stock Forecast 2026 $3.64 — Price, Financials & Analyst Targets | Alpha Lenz